Evidence map›Paper›PMID 24914339›Full record

ReviewWorld journal of gastroenterology2014

Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.

Xiao-Li Zhan, Yun Ji, Yue-Dong Wang

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Splenectomy and risk of hepatocellular carcinoma.World journal of hepatology · 2025
    Review
  7. Cytopenias in Autoimmune Liver Diseases-A Review.Journal of clinical medicine · 2025
    Review
  8. CD300EExperimental & molecular medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Quest for the optimal technique of laparoscopic splenectomy - vessels first or hilar transection?Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiao-Li ZhanXiao-Li Zhan, Yun Ji, Yue-Dong Wang, Department of General Surgery, Second Affiliated Hospital Zhejiang University College of Medicine, 88 Jiefang RD, Hangzhou 310009, Zhejiang Province, China.
Yun JiXiao-Li Zhan, Yun Ji, Yue-Dong Wang, Department of General Surgery, Second Affiliated Hospital Zhejiang University College of Medicine, 88 Jiefang RD, Hangzhou 310009, Zhejiang Province, China.
Yue-Dong WangXiao-Li Zhan, Yun Ji, Yue-Dong Wang, Department of General Surgery, Second Affiliated Hospital Zhejiang University College of Medicine, 88 Jiefang RD, Hangzhou 310009, Zhejiang Province, China.
Second Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first laparoscopic splenectomy (LS) was reported in 1991, LS has become the gold standard for the removal of normal to moderately enlarged spleens in benign conditions. Compared with open splenectomy, fewer postsurgical complications and better postoperative recovery have been observed, but LS is contraindicated for hypersplenism secondary to liver cirrhosis in many institutions owing to technical difficulties associated with splenomegaly, well-developed collateral circulation, and increased risk of bleeding. With the improvements of laparoscopic technique, the concept is changing. This article aims to give an overview of the latest development in laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension. Despite a lack of randomized controlled trial, the publications obtained have shown that with meticulous surgical techniques and advanced instruments, LS is a technically feasible, safe, and effective procedure for hypersplenism secondary to cirrhosis and portal hypertension and contributes to decreased blood loss, shorter hospital stay, and less impairment of liver function. It is recommended that the dilated short gastric vessels and other enlarged collateral circulation surrounding the spleen be divided with the LigaSure vessel sealing equipment, and the splenic artery and vein be transected en bloc with the application of the endovascular stapler. To support the clinical evidence, further randomized controlled trials about this topic are necessary.

Indexed as

ChildHumansHypersplenismHypertension, PortalLaparoscopyLength of StayLiver CirrhosisMinimally Invasive Surgical ProceduresSpleenSplenectomySplenic ArterySplenic VeinSplenomegalySurgical Procedures, OperativeTreatment OutcomeHypersplenismLaparoscopyLiver cirrhosisPortal hypertensionSplenectomy

Identifiers

PMID24914339
PMCPMC4024788
OpenAlexW2039125429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.